Assessing morbidity, mortality, and survival in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Assessing morbidity, mortality, and survival in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

ABSTRACT Peritoneal carcinomatosis (PC) indicates advanced stage cancer, which is generally associated with a poor outcome and a 6 to 12 months. Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is an option for treating patients with primary PC, such as mesothelioma...

Full description

Bibliographic Details
Main Authors: JAIRO SEBASTIÁN ASTUDILLO VALLEJO, FABIO LOPES DE QUEIROZ, ANTÔNIO LACERDA FILHO, PAULO ROCHA FRANÇA NETO, BRENO XAIA MARTINS DA COSTA, RODRIGO ALMEIDA PAIVA, SILVÉRIO LEONARDO MACEDO GARCIA, SERGIO BOTREL SILVA
Format: Article
Language:English
Published: Colégio Brasileiro de Cirurgiões 2023-04-01
Series:Revista do Colégio Brasileiro de Cirurgiões
Subjects:
Mortality
Survival
Peritoneal Diseases
Cytoreduction Surgical Procedures
Hyperthermic Intraperitoneal Chemotherapy
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-69912023000100212&tlng=pt

Similar Items

Similar Items